volume 54 issue 7 pages 763-771

AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype

Publication typeJournal Article
Publication date2006-03-03
scimago Q1
wos Q4
SJR0.875
CiteScore5.6
Impact factor1.5
ISSN00221554, 15515044
Histology
Anatomy
Abstract

CD163 is a member of the scavenger receptor cysteine-rich superfamily restricted to the monocyte/macrophage lineage and is thought to be a useful marker for anti-inflammatory or alternatively activated macrophages. In this study we used mass spectrometric analysis to determine that the antigen recognized by the antibody AM-3K, which we previously generated as a tissue macrophage-specific monoclonal antibody, was CD163. An anti-inflammatory subtype of macrophages stimulated by dexamethasone or interleukin-10 showed strong reactivity for AM-3K and increased expression of CD163 mRNA. Immunohistochemical staining of routinely processed pathological specimens revealed that AM-3K recognized a specialized subpopulation of macrophages. In granulomatous diseases such as tuberculosis, sarcoidosis, or foreign body reactions, tissue macrophages around granulomas, but not component cells of the granulomas such as epithelioid cells and multinucleated giant cells, showed positive staining for AM-3K. In atherosclerotic lesions, scattered macrophages in diffuse intimal lesions were strongly positive for AM-3K, whereas foamy macrophages in atheromatous plaques demonstrated only weak staining. We therefore suggest that, in routine pathological specimens, AM-3K is a useful marker for anti-inflammatory macrophages because these cells can be distinguished from inflammatory or classically activated macrophages. Because AM-3K cross-reacts with macrophage subpopulations in different animal species including rats, guinea pigs, rabbits, cats, dogs, goats, pigs, bovine species, horses, monkeys, and cetaceans, it will have wide application for detection of CD163 in various animals.

Found 
Found 

Top-30

Journals

1
2
3
4
5
6
7
8
9
Cancer Science
9 publications, 5.77%
Pathology International
6 publications, 3.85%
Chemical and Pharmaceutical Bulletin
4 publications, 2.56%
International Journal of Molecular Sciences
4 publications, 2.56%
PLoS ONE
4 publications, 2.56%
Frontiers in Immunology
3 publications, 1.92%
Veterinary Immunology and Immunopathology
3 publications, 1.92%
International Journal of Cancer
3 publications, 1.92%
Journal of Immunology
2 publications, 1.28%
Journal of Veterinary Diagnostic Investigation
2 publications, 1.28%
Veterinary Pathology
2 publications, 1.28%
Animals
2 publications, 1.28%
Arthritis Research and Therapy
2 publications, 1.28%
Histochemistry and Cell Biology
2 publications, 1.28%
Reproductive Sciences
2 publications, 1.28%
PLoS Pathogens
2 publications, 1.28%
Journal of Neuroimmunology
2 publications, 1.28%
American Journal of Reproductive Immunology
2 publications, 1.28%
Journal of Clinical and Experimental Hematopathology
2 publications, 1.28%
Journal of Veterinary Medical Science
2 publications, 1.28%
American Journal of Respiratory and Critical Care Medicine
1 publication, 0.64%
Oncotarget
1 publication, 0.64%
Acta Haematologica
1 publication, 0.64%
Clinical Science
1 publication, 0.64%
Annals of Surgery
1 publication, 0.64%
Medicine (United States)
1 publication, 0.64%
Journal of Clinical Rheumatology
1 publication, 0.64%
NeuroReport
1 publication, 0.64%
American Journal of Surgical Pathology
1 publication, 0.64%
1
2
3
4
5
6
7
8
9

Publishers

5
10
15
20
25
30
35
40
Wiley
39 publications, 25%
Elsevier
30 publications, 19.23%
Springer Nature
21 publications, 13.46%
MDPI
10 publications, 6.41%
SAGE
8 publications, 5.13%
Ovid Technologies (Wolters Kluwer Health)
6 publications, 3.85%
Public Library of Science (PLoS)
6 publications, 3.85%
Pharmaceutical Society of Japan
4 publications, 2.56%
Frontiers Media S.A.
4 publications, 2.56%
The American Association of Immunologists
2 publications, 1.28%
Taylor & Francis
2 publications, 1.28%
Japanese Society for Lymphoreticular Tissue Research
2 publications, 1.28%
Institute of Electronics, Information and Communications Engineers (IEICE)
2 publications, 1.28%
Oxford University Press
2 publications, 1.28%
Hindawi Limited
2 publications, 1.28%
American Thoracic Society
1 publication, 0.64%
Impact Journals
1 publication, 0.64%
S. Karger AG
1 publication, 0.64%
Portland Press
1 publication, 0.64%
Georg Thieme Verlag KG
1 publication, 0.64%
American Chemical Society (ACS)
1 publication, 0.64%
Universita Palackeho Olomouc
1 publication, 0.64%
Japan Atherosclerosis Society
1 publication, 0.64%
Japanese Society of Anti-Aging Medicine
1 publication, 0.64%
BMJ
1 publication, 0.64%
American Association for the Advancement of Science (AAAS)
1 publication, 0.64%
American Society for Microbiology
1 publication, 0.64%
American Association for Cancer Research (AACR)
1 publication, 0.64%
American Society of Clinical Oncology (ASCO)
1 publication, 0.64%
5
10
15
20
25
30
35
40
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
156
Share
Cite this
GOST |
Cite this
GOST Copy
Komohara Y. et al. AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype // Journal of Histochemistry and Cytochemistry. 2006. Vol. 54. No. 7. pp. 763-771.
GOST all authors (up to 50) Copy
Komohara Y., Hirahara J., Horikawa T., Kawamura K., Kiyota E., SAKASHITA N., Araki N., Takeya M. AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype // Journal of Histochemistry and Cytochemistry. 2006. Vol. 54. No. 7. pp. 763-771.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1369/jhc.5a6871.2006
UR - https://doi.org/10.1369/jhc.5a6871.2006
TI - AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype
T2 - Journal of Histochemistry and Cytochemistry
AU - Komohara, Yoshihiro
AU - Hirahara, Junko
AU - Horikawa, Tomohiro
AU - Kawamura, Kyoko
AU - Kiyota, Emi
AU - SAKASHITA, Naomi
AU - Araki, Norie
AU - Takeya, M.
PY - 2006
DA - 2006/03/03
PB - SAGE
SP - 763-771
IS - 7
VL - 54
PMID - 16517975
SN - 0022-1554
SN - 1551-5044
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2006_Komohara,
author = {Yoshihiro Komohara and Junko Hirahara and Tomohiro Horikawa and Kyoko Kawamura and Emi Kiyota and Naomi SAKASHITA and Norie Araki and M. Takeya},
title = {AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype},
journal = {Journal of Histochemistry and Cytochemistry},
year = {2006},
volume = {54},
publisher = {SAGE},
month = {mar},
url = {https://doi.org/10.1369/jhc.5a6871.2006},
number = {7},
pages = {763--771},
doi = {10.1369/jhc.5a6871.2006}
}
MLA
Cite this
MLA Copy
Komohara, Yoshihiro, et al. “AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype.” Journal of Histochemistry and Cytochemistry, vol. 54, no. 7, Mar. 2006, pp. 763-771. https://doi.org/10.1369/jhc.5a6871.2006.